Keywords: فاکتور V; TS; thrombotic storm; CS; chondroitin sulfate; APS; antiphospholipid antibody syndrome; aPL; antiphospholipid antibodies; TM; thrombomodulin; PROC; protein C; PROS1; protein S; PLG; plasminogen; PLAT; plasminogen activator; WES; whole exome sequencing; CG
مقالات ISI فاکتور V (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فاکتور V; ATII; alveolar epithelial type II; AIIt; annexin A2 heterotetramer; APC; activated protein C; BALF; broncho-alveolar lavage fluid; DAD; diffuse alveolar damage; EGF; epidermal growth factor; ECM; extracellular matrix; FAK; focal adhesion kinase; FV; facto
Keywords: فاکتور V; aPCC; activated prothrombin complex concentrate; aPL; antiphospholipid; FIX; factor IX; FMD; flow-mediated dilatation; FV; factor V; FVIII; factor VIII; HA; hemophilia A; HB; hemophilia B; HIV; human immunodeficiency virus; IMT; intima-media thickness; MT
Keywords: فاکتور V; structural bioinformatics; blood coagulation; cancer; factor VIII; factor V; neuropilin
Keywords: فاکتور V; Young; stroke; hypercoagulable state; MTHFR; Factor V;
Keywords: فاکتور V; FV; Factor V; FVIIa; Factor VIIa; FX/FXa; Factor X/Factor Xa; IgG; immunoglobulin; LPS; lipopolysaccharide; PCA; procoagulant activity; PMA; phorbol myristate acetate; PRP; platelet rich plasma; PS; phosphatidylserine; PSGL-1; P-selectin glycoprotein liga
Association of factor V activity with risk of venous thromboembolism and atherothrombotic cardiovascular events: A retrospective population-based cohort study
Keywords: فاکتور V; Factor V; Myocardial infarction; Stroke; Transient ischemic attack; TIA; Venous thromboembolism; VTE;
Cellular uptake of coagulation factor VIII: Elusive role of the membrane-binding spikes in the C1 domain
Keywords: فاکتور V; Factor VIII; Low density lipoprotein receptor-related protein 1; Receptor-mediated endocytosis; α2-macroglobulin; Factor V;
Efficacy of solvent/detergent plasma after storage at 2-8â°C for 5 days in comparison to other plasma products to improve factor V levels in factor V deficient plasma
Keywords: فاکتور V; Factor V; Plasma; Trauma; Thromboelastometry; Fresh frozen plasma;
Managing Menorrhagia in a Familial Case of Factor V Deficiency
Keywords: فاکتور V; Factor V; Menorrhagia; Intrauterine devices; Oral contraceptives
Pro- and anti-inflammatory effects of histamine on tissue factor and TNFα expression in monocytes of human blood
Keywords: فاکتور V; ASA; acetylsalicylic acid; FV; Factor V; FVIIa; activated Factor VII; FXa; activated Factor X; LPS; lipopolysaccharide; TF; tissue factor; PMA; phorbol myristate acetate; PKC; protein kinase C; PKD; protein kinase D; PSGL-1; P-selectin glycoprotein-1; TNF
Anticoagulant factor V: Factors affecting the integration of novel scientific discoveries into the broader framework
Keywords: فاکتور V; Factor V; Factor V Leiden; Thrombophilia; Coagulation cascade; Anticoagulant;
Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: A systematic review and meta-analysis
Keywords: فاکتور V; Behcet syndrome; Factor V; Prothrombin; Methylenetetrahydrofolate reductase; Polymorphism; Genetic; Meta-analysis;
Clinical and laboratory diagnosis of autoimmune factor V inhibitors: A single institutional experience
Keywords: فاکتور V; Factor V; Thrombin; Hemostasis; Blood coagulation factor inhibitors; Lupus anticoagulant inhibitor;
Multiplex primer extension reaction and capillary electrophoresis to study the frequency of thrombophilia-related mutations in a spanish population
Keywords: فاکتور V; FV; Factor V Leiden G1691A; PT; prothrombin G20210A; F12; factor XII; MTHFR; methylenetetrahydrofolate reductase C677T; Thrombophilia; Factor V; Prothrombin; Factor XII; Genetic analysis;
Assembly of the prothrombinase complex on the surface of human foreskin fibroblasts: Implications for connective tissue growth factor
Keywords: فاکتور V; FXa; activated factor X; CTGF/CCN2; connective tissue growth factor; TF; tissue factor; TSP1; thrombospondin-1; HFF; human foreskin fibroblasts; FVII; factor VII; FX; factor X; FV; factor V; II; prothrombin; TGFβ; transforming growth factor beta; TGFβRI
Global haemostasis assays, from bench to bedside
Keywords: فاکتور V; α; angle that assesses rate of clot formation; α2M; α2-macroglobulin; AMC; 7-amino-4-methylcoumarine; AT; antithrombin; AUC; area under the curve; APC; activated protein C; aPTT; activated partial thromboplastin time; A10; the amplitude after ten minut
Laboratory identification of factor inhibitors: an update
Keywords: فاکتور V; APTT; Bethesda assay; Factor inhibitors; lupus inhibitor; mixing tests; replacement therapy; APTT; activated partial thromboplastin time; aVWS; acquired von Willebrand syndrome; DIC; disseminated intravascular coagulation; dRVVT; dilute Russell's viper
Hemophilic Synovitis: Factor VII and the Potential Role of Extravascular Factor VIIa
Keywords: فاکتور V; TF, tissue factor; FVIIa, activated Factor VII; rFVIIa, recombinant activated factor VII; EPCR, endothelial protein C receptor; TFPI, tissue factor pathway inhibitor; I.A., intraarticular; I.V., intravenous; AAV, adeno-associated virusFactor VII; Factor V
The R306G and R506Q mutations in coagulation Factor V reveals additional cleavage sites for Activated Protein C in the R313-R321 region and at R505
Keywords: فاکتور V; Factor V; APC; APC resistance; mutants; thrombosis
The platelet hyporeactivity of extremely low birth weight neonates is age-dependent
Keywords: فاکتور V; ELBW, extremely low birth weight; FITC, fluorescein isothiocyanate; GP, glycoprotein; PE, phycoerythrinBlood platelets; P-selectin; Glycoprotein Ib; Factor V; Prematurity; Intraventricular hemorrhage
Prevalence of genetic thrombophilic polymorphisms in the Sri Lankan population — implications for association study design and clinical genetic testing services
Keywords: فاکتور V; Methylenetetrahydrofolate reductase; Factor V; Factor II; Population genetics
A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms
Keywords: فاکتور V; Factor V; Deep venous thrombosis; Single nucleotide polymorphisms
Increased venous versus arterial thrombosis in the Factor V Leiden mouse
Keywords: فاکتور V; Arterial thrombosis; Coagulation; Deep vein thrombosis; Factor V; Venous thromboembolism
Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: A multicenter, randomized, double-blind study
Keywords: فاکتور V; HRT; hormone replacement therapy; SERM; selective estrogen receptor modulator; CCHT; continuous combined hormone therapy; FSH; follicle-stimulating hormone; FVII; factor VII; FVIII; factor VIII; F1Â +Â 2; prothrombin fragments 1 and 2; PAI; plasminogen ac
Crystal Structure of the Bovine Lactadherin C2 Domain, a Membrane Binding Motif, Shows Similarity to the C2 Domains of Factor V and Factor VIII
Keywords: فاکتور V; crystal structure; C2 domain; lactadherin; factor V; factor VIII
The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy
Keywords: فاکتور V; Hepatitis; Coagulation; Factor VII; Factor V; PTT; partial prothrombin time; PT; prothrombin time; INR; international normalized ratio; AST; aspartate aminotransferase; ALT; alanine aminotransferase;
Full length nucleotide sequence of a Factor V-like subunit of oscutarin from Oxyuranus scutellatus scutellatus (coastal Taipan)
Keywords: فاکتور V; Factor V; Oxyuranus; Nucleotide sequence;
A review of the effects of the oral direct thrombin inhibitor ximelagatran on coagulation assays
Keywords: فاکتور V; ACT; activated clotting time; APTT; activated partial thromboplastin time; DTI; direct thrombin inhibitor; ECT; ecarin clotting time; FV; factor V; IC50; plasma concentration of anticoagulant agent that doubles the clotting time compared with anticoagulan
Thromsbospondin-1 binds to the heavy chain of elastase activated coagulation factor V (FVaHNE) and enhances thrombin generation on the surface of a promyelocytic cell line
Keywords: فاکتور V; TSP1; thrombospondin-1; HNE; human neutrophil elastase; HBSS; Hanks Balanced Salt Solution; RT-PCR; reverse trasnscriptase polymerase chain reaction; APL; acute promyelocytic leukemia; HBD; heparin binding site; TFPI; tissue factor pathway inhibitor; FXa;